US Stock MarketDetailed Quotes

NRXP NRX Pharmaceuticals

Watchlist
  • 3.5400
  • +0.4000+12.74%
Close Apr 26 16:00 ET
  • 3.8000
  • +0.2600+7.34%
Post 19:56 ET
37.13MMarket Cap-885P/E (TTM)

NRX Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

NRX Pharmaceuticals Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

Mar 28, 2024

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.50

+66.67%
Analyst Rating

No Data

NRX Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 0.000--
--2024/Q1-- / 0.000--
Mar 28, 20242023/Q40.000 / 0.000--
Nov 14, 20232023/Q30.000 / 0.000--
Aug 14, 20232023/Q20.000 / 0.000--
May 16, 20232023/Q10.000 / 0.000--
Mar 30, 20232022/Q40.000 / 0.000--
Nov 14, 20222022/Q30.000 / 0.000--
Aug 15, 20222022/Q20.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 0.000--
--2024/Q1-- / 0.000--
Mar 28, 20242023/Q40.000 / 0.000--
Nov 14, 20232023/Q30.000 / 0.000--
Aug 14, 20232023/Q20.000 / 0.000--
May 16, 20232023/Q10.000 / 0.000--
Mar 30, 20232022/Q40.000 / 0.000--
Nov 14, 20222022/Q30.000 / 0.000--
Aug 15, 20222022/Q20.000 / 0.000--
--------

Unlock Free Earnings Estimates

NRX Pharmaceuticals Earnings Reports

  • NRX Pharmaceuticals | 10-K: Annual report

    Mar 29 17:23 ET

  • NRX Pharmaceuticals: Q3 2023 Earnings Report

    Nov 14, 2023 16:01 ET

  • NRX Pharmaceuticals | 10-Q: Q2 2023 Earnings Report

    Aug 14, 2023 16:34 ET

  • NRX Pharmaceuticals | 10-K/A: Annual report (Amendment)

    May 26, 2023 17:00 ET

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg
    Concept Top Gainers Yesterday
    Top Gainers Yesterday
    Intraday-1.04%